EBITDA Margin % is calculated as EBITDA divided by its Revenue. Earth Science Tech's EBITDA for the
three
months ended in Mar. 2026 was $0.59 Mil. Earth Science Tech's Revenue for the
three
months ended in Mar. 2026 was $9.50 Mil. Therefore, Earth Science Tech's EBITDA margin for the quarter that ended in Mar. 2026 was 6.21%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Earth Science Tech EBITDA Margin % Related Terms
Earth Science Tech EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Earth Science Tech's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETST vs SCYX, INIS, TLPH: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Science Tech EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Earth Science Tech's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Science Tech (ETST) has a EBITDA Margin % of 6.21% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Earth Science Tech and its competitors. According to the industry distribution chart, Earth Science Tech ranks #547 out of 952 companies in the Drug Manufacturers industry, placing it in the top 57.5%.
Is Earth Science Tech's EBITDA Margin % too high?
Earth Science Tech's current EBITDA Margin % is 6.21%. The Drug Manufacturers industry median EBITDA Margin % is 12.47. Earth Science Tech's value of 6.21% is 50.2% below this industry median. Based on the distribution chart, Earth Science Tech ranks #547 out of 952 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Earth Science Tech has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Earth Science Tech's EBITDA Margin % compare to SCYX and INIS?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #547 out of 952 companies for EBITDA Margin %. This places Earth Science Tech in the lower half of its industry. The industry median EBITDA Margin % is 12.47. Earth Science Tech's value of 6.21% is 50.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current EBITDA Margin % of 6.21% is 50.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current EBITDA Margin % is 6.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Based on GuruFocus' analysis, Earth Science Tech (ETST) is currently considered Possible Value Trap. The stock's GF Value™ is $0.23, compared to a current price of $0.16 — trading 30.4% below its estimated fair value. The current EBITDA Margin % is 6.21% and 50.2% below the Drug Manufacturers industry median of 12.47. Earth Science Tech's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Earth Science Tech (ETST), the current EBITDA Margin % is 6.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Earth Science Tech (ETST) Overvalued in 2026?
Based on GuruFocus' analysis, Earth Science Tech stock appears to be undervalued.
The current stock price of $0.16 is trading 30.4% below its estimated GF Value™ of $0.23.
GuruFocus considers Earth Science Tech to be Possible Value Trap.
Key valuation signals for ETST:
EBITDA Margin %: 6.21%
GF Value™: $0.23 vs. price of $0.16 (30.4% below fair value)
Industry Position: 50.2% below the Drug Manufacturers median (#547 of 952)
No single metric tells the full story. See the ETST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
37GF Score
Get the complete analysis for ETST
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETST has been successfully added to your 
